Rheumatoid Arthritis - All SharePosts Relating To "Vioxx"

EXPERT

Mark Borigini, M.D.

(Profile)

Rheumatologist

Our Expert | Health Professional

RSS

posted 03/05/2008, comments (0)

Prescription Drug Advertising: Are consumers better off?

Many years ago, the tobacco industry was told to cease and desist: No more advertising on television for cigarettes. It endangered consumers. And so we all lost that ride-along on the plains with that steady, strong cowhand, cigarette dangling from his lower lip as he swaggered across our television screens. A generation... Read more Chevron

Read all my posts | Subscribe

EXPERT

Christine Miller

(Profile)

In Remission from JRA, Active April 2006 to February 2009

Our Expert | Living With It

RSS

posted 04/15/2007, comments (0)

FDA Advisors Reject Arcoxia

On April 12th, a Food and Drug Administration, FDA, advisory panel of experts rejected Merck’s drug, Arcoxia, in a 20-1 vote. It is a non-binding recommendation that the FDA should not approve the drug for the U.S. market. The FDA will be taken as advice and one factor to consider when the FDA is makes its decision whether or not to... Read more Chevron

Read all my posts | Subscribe

EXPERT

Christine Miller

(Profile)

In Remission from JRA, Active April 2006 to February 2009

Our Expert | Living With It

RSS

posted 04/11/2007, comments (0)

FDA Advisory Panel to Evaluate Arcoxia - Vioxx Replacement

On Thursday, April 12 an FDA advisory panel will discuss whether or not to recommend that the FDA approve Merck & Co’s COX-2 inhibitor, Arcoxia (etoricoxib). The drug is manufactured by Merck, the same company that made Vioxx, which was pulled from the market in the fall of 2004. Merck applied for approval to sell Arcoxia... Read more Chevron

Read all my posts | Subscribe

EXPERT

Christine Miller

(Profile)

In Remission from JRA, Active April 2006 to February 2009

Our Expert | Living With It

RSS

posted 03/15/2007, comment (1)

Merck Loses Another Vioxx Lawsuit

Health and finance media outlets are abuzz this week after a jury in New Jersey found that in the case of a Mr. Humeston of Idaho, Merck was intentionally and recklessly negligent in failing to provide adequate warning of the risks of taking Vioxx in the drug's package inserts. The jury also found that Vioxx contributed... Read more Chevron

Read all my posts | Subscribe

EXPERT

Christine Miller

(Profile)

In Remission from JRA, Active April 2006 to February 2009

Our Expert | Caregiver

RSS

posted 01/17/2007, comments (0)

Vioxx Heart Attack Risk Linked to Blood Clotting

A recent study may provide hope that scientists will one day be able to develop COX-2 inhibitor drugs, such as Celebrex and Vioxx, that do not have the associated risk of heart attacks and strokes. The research, published in the December issue of the Federation of American Societies for Experimental Biology (FASEB), found that Vioxx and the... Read more Chevron

Read all my posts | Subscribe